(Q28610274)

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Matrix metalloproteinases and the development of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Cloning, expression and activation of a truncated 92-kDa gelatinase minienzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Synthetic substrates of vertebrate collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Mechanistic studies on the human matrix metalloproteinase stromelysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Role of His-224 in the anomalous pH dependence of human stromelysin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently synthetic substrates containing unusual amino acids in their P1' positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Buffers of constant ionic strength for studying pH-dependent processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043

Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.46.33043